Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/356"

PredicateValue (sorted: none)
rdf:type
?:Evidence
rdf:type
?:Item
rdfs:label
"evidence_1263"
?:Evidence_type
?:Non_Tracable_Statement
?:Evidence_enzyme_system
""
dc:creator
"boycer"
dc:date
"06/17/2009 09:26:37"
?:content
"The FDA guidance considers DMT-O-demethylation to be catalyzed selectively by CYP2D6 in vitro (see Table 3 of page 32) and recommends it as an substrate for in vivo DDI PK studies (see Table 2 page 19)"
rdfs:seeAlso
?:FDA-Guidance-Drug-Interaction-Studies%E2%80%93Study%20Design-Data-Analysis-and-Implications-2006.pdf

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ dextromethorphan_in_viVo_probe_substrate_of_enzyme_cyp2d6, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1263 }

Context graph